News & Events about Baxter International Inc.
Combines Miromatrixs expertise in bioengineered organs with Baxters leadership in critical care delivery and organ support therapiesIncludes intended Phase I clinical trial designed to generate key evidence to support additional therapeutic options for patients suffering from acute liver failure ...
Baxter International (NYSE:BAX Get Rating) was downgraded by investment analysts at Morgan Stanley from an overweight rating to an equal weight rating in a research note issued to investors on Friday, The Fly reports. They presently have a $55.00 price target on ...
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders. These...
Baxter International Inc. (NYSE: BAX), a global medtech leader, today announced it was again named to the Dow Jones Sustainability Indices (DJSI), including both DJSI World and DJSI North America. Baxter has proudly been included in the DJSI World and DJSI North America each year since they...
Ticker Report
2 months ago
Shares of Baxter International Inc. (NYSE:BAX Get Rating) have been assigned an average rating of Hold from the seventeen analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a...